Phase 2a proof-of-concept trial of EVO301 in adults with moderate-to-severe atopic dermatitis (AD) during a late-breaking oral presentation at the European Academy of Dermatology and Venereology (EADV ...
Artiva Biotherapeutics, Inc. highlighted updated clinical, safety and translational data for AlloNK (also known as AB-101) in combination with rituximab, in an oral session at the 17th International ...
It's no secret that spending on AI data centers is booming, and projections for hyperscaler spending suggest the boom will ...
AI is changing search, but some of the loudest claims about traffic, content, measurement, and SEO jobs don’t hold up when ...
Kensington, MD, USA, and Munich/Martinsried, Germany, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Data presented at EURETINA 2026 ...
Zealand Pharma (ZEAL) stock fell 12% after its obesity drug trial showed strong weight loss but high patient dropout from ...
Base activates its Cobalt upgrade, adding conditional transactions and new compliance tools for tokenized assets on its ...
Governments must stop viewing the sharing of chemical data as a surrender of sovereignty and instead appreciate it as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results